These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 37375450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs.
    Park SH, Lee SY, Kim JS, Kim AY, Park SY, Lee JH, Lee M, Kim H, Lee SI, Kang NY, Park JW, Kim SM, Park JH, Ko YJ.
    Vaccines (Basel); 2021 Jun 02; 9(6):. PubMed ID: 34199359
    [Abstract] [Full Text] [Related]

  • 5. Protein characterization of an Indonesian isolate of foot and mouth disease virus inactivated with formaldehyde and binary ethylenimine.
    Kurniawan Y, Tyasningsih W, Rahmahani J, Puspitasari Y, Kusnoto K, Azzahra F, Tobing TM, Aswin A, Diyantoro D, Maulana FK, Susilowati H, Kuncorojakti S, Rantam FA.
    Vet World; 2024 Aug 02; 17(8):1836-1845. PubMed ID: 39328437
    [Abstract] [Full Text] [Related]

  • 6. Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods.
    Mahdy Sel D, Hassanin AI, Gamal El-Din WM, Ibrahim Eel-S, Fakhry HM.
    Vet World; 2015 Sep 02; 8(9):1088-98. PubMed ID: 27047204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of different inactivants and preservatives on the stability of 146S fraction of foot-and-mouth diseases virus.
    Tariq M, Ayub F, Altaf I, Bashir R, Bin Shabir S, Almas S.
    Vet Res Forum; 2024 Sep 02; 15(7):351-356. PubMed ID: 39257459
    [Abstract] [Full Text] [Related]

  • 13. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ, Cassim NI.
    Dev Biol (Basel); 2004 Sep 02; 119():449-55. PubMed ID: 15742659
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.
    Rizvi A, Hussain N, Anjum AA, Ahmed N, Naeem A, Khan M, Altaf I.
    J Virol Methods; 2022 Feb 02; 300():114379. PubMed ID: 34826516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens.
    Kim AY, Kim H, Park SY, Park SH, Kim JS, Park JW, Park JH, Ko YJ.
    Vaccines (Basel); 2021 Mar 12; 9(3):. PubMed ID: 33809252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Mahapatra M, Upadhyaya S, Aviso S, Babu A, Hutchings G, Parida S.
    Vaccine; 2017 Dec 18; 35(51):7147-7153. PubMed ID: 29157957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.